ENVB · Enveric Biosciences Inc
United States · RS rating 24 · As of 2026-10-14
| Price | 1.37 USD |
|---|---|
| 1-day change | -2.1% |
| RS rating (overall / 1M / 3M / 12M) | 24 / 33 / 67 / 5 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 26 / 17 / 48 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +29.6% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +87.3% |
| Market cap (USD) | $8.0M |